NDC 74695-823
VIVJOA
Oteseconazole
VIVJOA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Mycovia Pharmaceuticals, Inc.. The primary component is Oteseconazole.
| Product ID | 74695-823_e3a11f7b-9608-a1d3-e053-2995a90aca2b |
| NDC | 74695-823 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VIVJOA |
| Generic Name | Oteseconazole |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-07-11 |
| Marketing Category | NDA / |
| Application Number | NDA215888 |
| Labeler Name | Mycovia Pharmaceuticals, Inc. |
| Substance Name | OTESECONAZOLE |
| Active Ingredient Strength | 150 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 74695-823-18
1 CONTAINER in 1 CARTON (74695-823-18) > 1 BLISTER PACK in 1 CONTAINER > 18 CAPSULE in 1 BLISTER PACK
| Marketing Start Date | 2022-07-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
Trademark Results [VIVJOA]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 VIVJOA 88831981 not registered Live/Pending |
Mycovia Pharmaceuticals, Inc. 2020-03-12 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.